Eliezer Katz

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 717 citations

Medicine, Neurology, Pharmacotherapy +4

Primary Blast Injury After a Bomb Explosion in a Civilian Bus

Eliezer Katz, Boaz Ofek, J Adler et al. · Annals of Surgery · 1989 · 227 citations

Engineering, Emergency Medicine, Disaster Medicine +10

Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study

Mark Agius, Gabriela Kłodowska-Duda, Maciej Maciejowski et al. · Multiple Sclerosis Journal · 2017 · 142 citations · Full text

Life Sciences, Immunology, Neurology +17

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

Orhan Aktaş, Michael Smith, William A. Rees et al. · Annals of Neurology · 2021 · 136 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Neuromyelitis optica spectrum disorder

Janine B. Beekman, Aysha Keisler, Omar Pedraza et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 131 citations · Full text

Medicine, Neurology, Health Psychology +16